For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
MPKALPVIDTSAPVCCAPVAAGPMSDDDALSVALRLKALADPARVKLMSYLFSSETGEENSGDLAVALGL RESTVSHHLAQLRKAGLVVSERRGMNVFHRAHPEALRALCVVLDPNCCR
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. smegmatis MC2 155 | MSMEG_1175 | - | - | 100% (119) | putative transcriptional regulatory protein |
| M. smegmatis MC2 155 | MSMEG_1173 | - | 5e-17 | 42.45% (106) | transcriptional regulator, ArsR family protein |
| M. smegmatis MC2 155 | MSMEG_5405 | - | 3e-06 | 32.93% (82) | transcriptional regulator, ArsR family protein |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb2673c | - | 9e-53 | 81.36% (118) | ArsR family transcriptional regulator |
| M. gilvum PYR-GCK | Mflv_1652 | - | 2e-48 | 76.27% (118) | regulatory protein, ArsR |
| M. tuberculosis H37Rv | Rv2640c | - | 9e-53 | 81.36% (118) | ArsR family transcriptional regulator |
| M. leprae Br4923 | - | - | - | - | - |
| M. abscessus ATCC 19977 | MAB_2565c | - | 1e-49 | 78.15% (119) | ArsR family transcriptional regulator |
| M. marinum M | MMAR_2058 | - | 1e-49 | 78.81% (118) | ArsR family transcriptional regulator |
| M. avium 104 | MAV_1492 | - | 8e-40 | 67.80% (118) | putative transcriptional regulator |
| M. thermoresistible (build 8) | TH_0142 | - | 7e-50 | 78.15% (119) | POSSIBLE TRANSCRIPTIONAL REGULATORY PROTEIN (PROBABLY |
| M. ulcerans Agy99 | MUL_3285 | - | 1e-49 | 78.81% (118) | ArsR family transcriptional regulator |
| M. vanbaalenii PYR-1 | Mvan_4825 | - | 1e-51 | 80.51% (118) | regulatory protein, ArsR |
CLUSTAL 2.0.9 multiple sequence alignment
Mb2673c|M.bovis_AF2122/97 ---------MPKSLPVIDISAPVCCAPVAAGPMSDGDALAVALRLKALAD
Rv2640c|M.tuberculosis_H37Rv ---------MPKSLPVIDISAPVCCAPVAAGPMSDGDALAVALRLKALAD
MMAR_2058|M.marinum_M ---------MPKALPVIDISAPVCCAPVAAGPIGDDDALAVALRLKALAD
MUL_3285|M.ulcerans_Agy99 ---------MPKALPVIDISAPVCCAPVAAGPIGDDDALAVALRLKALAD
MSMEG_1175|M.smegmatis_MC2_155 ---------MPKALPVIDTSAPVCCAPVAAGPMSDDDALSVALRLKALAD
MAB_2565c|M.abscessus_ATCC_199 ---------MPKALPLVDTSAPVCCAPVAAGPMSDDQALEVALRLKALAD
Mvan_4825|M.vanbaalenii_PYR-1 MSTDWHNRVMPKALPSIDISAPVCCAPVAAGPMSDEDALQVALRLKALAD
Mflv_1652|M.gilvum_PYR-GCK ---------MPKSLPLVDMSAPVCCAPVAAGPVGDDAALEIALRLKALAD
TH_0142|M.thermoresistible__bu ---------MPKALPVIDMSDPVCCAPVAAGPLSDADALEVAMRLKALAD
MAV_1492|M.avium_104 ---------MPKTLPVIDMSEPVCCAPVAAGPADDAAALDVAMRLKALAD
***:** :* * *********** .* ** :*:*******
Mb2673c|M.bovis_AF2122/97 PARVKIMSYLFSSPAGEQVSGQLAAALSLSDGTVSHHLAQLRKAGLVISD
Rv2640c|M.tuberculosis_H37Rv PARVKIMSYLFSSPAGEQVSGQLAAALSLSDGTVSHHLAQLRKAGLVISD
MMAR_2058|M.marinum_M PARVKIMSLLFGSPAGEEISGTLATALNLSDGTVSHHLTQLRKAGLVVSE
MUL_3285|M.ulcerans_Agy99 PARVKIMSLLFGSPAGEEISGTLATALNLSDGTVSHHLTQLRKAGLVVSE
MSMEG_1175|M.smegmatis_MC2_155 PARVKLMSYLFSSETGEENSGDLAVALGLRESTVSHHLAQLRKAGLVVSE
MAB_2565c|M.abscessus_ATCC_199 PVRVKIMSELFGAPDGEVISGDLAELLGLTESTVSHHMNQLRRAGLVESD
Mvan_4825|M.vanbaalenii_PYR-1 PARVKIMSHLYSSAAGEENSGSLAKVLGLTESTVSHHLSQLRRAGLVESD
Mflv_1652|M.gilvum_PYR-GCK PARVKLMSLLFSSPANEENSGDLAHGLGLSESTVSHHLTQLRKAGLVESE
TH_0142|M.thermoresistible__bu PARVKIMSLLFSSRSGEATSGDLAATLDLAESTVSHHIGQLRKAGMVVSD
MAV_1492|M.avium_104 PVRVKLMSLLFT-ADGTCTTGSLAAAVGLSESTVSHHLGQLRTAGFVASD
*.***:** *: . :* ** :.* :.*****: *** **:* *:
Mb2673c|M.bovis_AF2122/97 RRGMHVFHRVHPEALQALCTVLNPNCCA
Rv2640c|M.tuberculosis_H37Rv RRGMHVFHRVHPEALQALCTVLNPNCCA
MMAR_2058|M.marinum_M RRGMHVFHRVHTEALQALCAVLSPDCCT
MUL_3285|M.ulcerans_Agy99 RRGMHVFHRVHTEALQALCAVLSPDCCT
MSMEG_1175|M.smegmatis_MC2_155 RRGMNVFHRAHPEALRALCVVLDPNCCR
MAB_2565c|M.abscessus_ATCC_199 RRGMNVFHRPVPDALTALCTVLDPNCCR
Mvan_4825|M.vanbaalenii_PYR-1 RRGMNVYHRPHRDAIGALCVVLDPNCCA
Mflv_1652|M.gilvum_PYR-GCK RRGMSVYHRVRRDSLSALCMVLDPDCCT
TH_0142|M.thermoresistible__bu RRGINVFHRVKPEALQALRAVLDPNCCR
MAV_1492|M.avium_104 RQGMSVHHTARREALTALCRVLDPSCCT
*:*: *.* ::: ** **.*.**